Online Only Articles

Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study

Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Erlangen, Germany
Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy
Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy
Azienda Ospedaliera Universitaria Consorziale, Policlinico di Bari, Italy
Azienda Ospedaliera di Padova, Clinica di Oncoematologia Pediatrica, Italy
First Department of Pediatrics, National and Kapodistrian University of Athens, Greece
Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy;Gianni Benzi Pharmacological Research Foundation, Bari, Italy
Centre for Medicines Optimisation Research and Education, Research Department of Practice & Policy, University College London School of Pharmacy, UK;Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China
Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Erlangen, Germany
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.176065